ALEXANDRIA, Va., Aug. 6 -- United States Patent no. 12,377,168, issued on Aug. 5, was assigned to University of Massachusetts (Westborough, Mass.).
"Gene therapies for usher syndrome (USH1B)" was invented by Hemant Khanna (Worcester, Mass.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Aspects of the disclosure relate to compositions and methods useful for delivering minigenes to a subject. Accordingly, the disclosure is based, in part, on isolated nucleic acids and gene therapy vectors, such as viral (e.g., rAAV) vectors, comprising one or more gene fragments encoding a therapeutic gene product, such as a protein or peptide (e.g. a minigene). In some embodiments, the disclosure relates to gene therapy vecto...